Photo taken from Fred R. Hirsch/X
Aug 25, 2024, 12:38
Fred R. Hirsch: What is the real impact of neo-adjuvant versus adjuvant therapy
Fred R. Hirsch, CEO of International Association for the Study of Lung Cancer, shared a post on X:
“I think we still need to know what is the real impact of neo-adjuvant versus adjuvant therapy.
We need to see results from prospective study (-ies) where each component is studied separately.”
Source: Fred R. Hirsch/X
Fred R. Hirsch is the CEO of International Association for the Study of Lung Cancer. He is a Professor and the Executive Director of the Thoracic Center at Tisch Cancer Institute, Mount Sinai. He is also a Professor Of Medicine and Pathology at the University of Colorado.